- Home
- JZ vs LVTX Comparison
JZ vs LVTX Comparison
Compare JZ & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- LVTX
- Stock Information
- Founded
- JZ 2011
- LVTX 2016
- Country
- JZ China
- LVTX Netherlands
- Employees
- JZ N/A
- LVTX N/A
- Industry
- JZ Other Consumer Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- LVTX Health Care
- Exchange
- JZ Nasdaq
- LVTX Nasdaq
- Market Cap
- JZ 26.7M
- LVTX 30.0M
- IPO Year
- JZ 2022
- LVTX 2021
- Fundamental
- Price
- JZ $0.39
- LVTX $1.27
- Analyst Decision
- JZ
- LVTX Hold
- Analyst Count
- JZ 0
- LVTX 3
- Target Price
- JZ N/A
- LVTX $3.17
- AVG Volume (30 Days)
- JZ 2.6M
- LVTX 46.7K
- Earning Date
- JZ 01-01-0001
- LVTX 05-14-2025
- Dividend Yield
- JZ N/A
- LVTX N/A
- EPS Growth
- JZ N/A
- LVTX N/A
- EPS
- JZ N/A
- LVTX N/A
- Revenue
- JZ $34,090,704.00
- LVTX $4,990,000.00
- Revenue This Year
- JZ N/A
- LVTX N/A
- Revenue Next Year
- JZ N/A
- LVTX N/A
- P/E Ratio
- JZ N/A
- LVTX N/A
- Revenue Growth
- JZ N/A
- LVTX N/A
- 52 Week Low
- JZ $0.51
- LVTX $0.85
- 52 Week High
- JZ $2.34
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- JZ 27.37
- LVTX 51.81
- Support Level
- JZ $0.51
- LVTX $1.22
- Resistance Level
- JZ $0.70
- LVTX $1.31
- Average True Range (ATR)
- JZ 0.13
- LVTX 0.08
- MACD
- JZ -0.04
- LVTX -0.00
- Stochastic Oscillator
- JZ 0.18
- LVTX 45.45
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.